Based on this information, we hypothesized that SsnB could suppress estrogen-dependent cell proliferation in breast and ovarian cancer cells and that this effect could develop through the inhibition of the PI3K/AKT/mTOR signaling pathway. The gene discussed is AKT1; the disease is ovarian carcinoma.